Literature DB >> 32980498

Fully Balanced SSFP Without an Endorectal Coil for Postimplant QA of MRI-Assisted Radiosurgery (MARS) of Prostate Cancer: A Prospective Study.

Jeremiah W Sanders1, Aradhana M Venkatesan2, Chad A Levitt3, Tharakeswara Bathala2, Rajat J Kudchadker4, Chad Tang5, Teresa L Bruno5, Christine Starks5, Edwin Santiago5, Michelle Wells3, Carl P Weaver3, Jingfei Ma6, Steven J Frank5.   

Abstract

PURPOSE: To investigate fully balanced steady-state free precession (bSSFP) with optimized acquisition protocols for magnetic resonance imaging (MRI)-based postimplant quality assessment of low-dose-rate (LDR) prostate brachytherapy without an endorectal coil (ERC). METHODS AND MATERIALS: Seventeen patients at a major academic cancer center who underwent MRI-assisted radiosurgery (MARS) LDR prostate cancer brachytherapy were imaged with moderate, high, or very high spatial resolution fully bSSFP MRIs without using an ERC. Between 1 and 3 signal averages (NEX) were acquired with acceleration factors (R) between 1 and 2, with the goal of keeping scan times between 4 and 6 minutes. Acquisitions with R >1 were reconstructed with parallel imaging and compressed sensing (PICS) algorithms. Radioactive seeds were identified by 3 medical dosimetrists. Additionally, some of the MRI techniques were implemented and tested at a community hospital; 3 patients underwent MARS LDR prostate brachytherapy and were imaged without an ERC.
RESULTS: Increasing the in-plane spatial resolution mitigated partial volume artifacts and improved overall seed and seed marker visualization at the expense of reduced signal-to-noise ratio (SNR). The reduced SNR as a result of imaging at higher spatial resolution and without an ERC was partially compensated for by the multi-NEX acquisitions enabled by PICS. Resultant image quality was superior to the current clinical standard. All 3 dosimetrists achieved near-perfect precision and recall for seed identification in the 17 patients. The 3 postimplant MRIs acquired at the community hospital were sufficient to identify 208 out of 211 seeds implanted without reference to computed tomography (CT).
CONCLUSIONS: Acquiring postimplant prostate brachytherapy MRI without an ERC has several advantages including better patient tolerance, lower costs, higher clinical throughput, and widespread access to precision LDR prostate brachytherapy. This prospective study confirms that the use of an ERC can be circumvented with fully bSSFP and advanced MRI scan techniques in a major academic cancer center and community hospital, potentially enabling postimplant assessment of MARS LDR prostate brachytherapy without CT.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32980498      PMCID: PMC7855300          DOI: 10.1016/j.ijrobp.2020.09.040

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  23 in total

1.  Generalized autocalibrating partially parallel acquisitions (GRAPPA).

Authors:  Mark A Griswold; Peter M Jakob; Robin M Heidemann; Mathias Nittka; Vladimir Jellus; Jianmin Wang; Berthold Kiefer; Axel Haase
Journal:  Magn Reson Med       Date:  2002-06       Impact factor: 4.668

2.  MR and CT image fusion for postimplant analysis in permanent prostate seed implants.

Authors:  Alfredo Polo; Federica Cattani; Andrea Vavassori; Daniela Origgi; Gaetano Villa; Hugo Marsiglia; Massimo Bellomi; Giampiero Tosi; Ottavio De Cobelli; Roberto Orecchia
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-12-01       Impact factor: 7.038

3.  Sparse MRI: The application of compressed sensing for rapid MR imaging.

Authors:  Michael Lustig; David Donoho; John M Pauly
Journal:  Magn Reson Med       Date:  2007-12       Impact factor: 4.668

4.  Automated seed localization from CT datasets of the prostate.

Authors:  D H Brinkmann; R W Kline
Journal:  Med Phys       Date:  1998-09       Impact factor: 4.071

5.  Parallel imaging compressed sensing for accelerated imaging and improved signal-to-noise ratio in MRI-based postimplant dosimetry of prostate brachytherapy.

Authors:  Jeremiah W Sanders; Hao Song; Steven J Frank; Tharakeswara Bathala; Aradhana M Venkatesan; Mitchell Anscher; Chad Tang; Teresa L Bruno; Wei Wei; Jingfei Ma
Journal:  Brachytherapy       Date:  2018-06-04       Impact factor: 2.362

Review 6.  Fundamentals of balanced steady state free precession MRI.

Authors:  Oliver Bieri; Klaus Scheffler
Journal:  J Magn Reson Imaging       Date:  2013-04-30       Impact factor: 4.813

7.  Pulse sequence considerations for simulation and postimplant dosimetry of prostate brachytherapy.

Authors:  Jingfei Ma; Marinus A Moerland; Aradhana M Venkatesan; Tharakeswara K Bathala; Rajat J Kudchadker; Kristy K Brock; Steven J Frank
Journal:  Brachytherapy       Date:  2017-01-04       Impact factor: 2.362

8.  A biodistribution and toxicity study of cobalt dichloride-N-acetyl cysteine in an implantable MRI marker for prostate cancer treatment.

Authors:  Steven J Frank; Mary J Johansen; Karen S Martirosyan; Mihai Gagea; Carolyn S Van Pelt; Agatha Borne; Yudith Carmazzi; Timothy Madden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-10-22       Impact factor: 7.038

9.  MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy.

Authors:  Juanita Crook; Michael McLean; Ivan Yeung; Theresa Williams; Gina Lockwood
Journal:  Brachytherapy       Date:  2004       Impact factor: 2.362

10.  Development and clinical implementation of SeedNet: A sliding-window convolutional neural network for radioactive seed identification in MRI-assisted radiosurgery (MARS).

Authors:  Jeremiah W Sanders; Steven J Frank; Rajat J Kudchadker; Teresa L Bruno; Jingfei Ma
Journal:  Magn Reson Med       Date:  2019-02-08       Impact factor: 4.668

View more
  1 in total

1.  Prospective Evaluation of Prostate and Organs at Risk Segmentation Software for MRI-based Prostate Radiation Therapy.

Authors:  Jeremiah W Sanders; Rajat J Kudchadker; Chad Tang; Henry Mok; Aradhana M Venkatesan; Howard D Thames; Steven J Frank
Journal:  Radiol Artif Intell       Date:  2022-01-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.